drugset / Trial / NCT00239317

Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Male Patients With Lower Urinary Tract Syndrome

NCT00239317 ↗

Phase 3 Completed Astellas Pharma Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether Tamusulosin is effective in the treatment of lower urinary tract syndrome with male patients.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Tamusulosin Unknown — —